A Bipartisan Coalition of 39 State Attorneys General Urge Congressional Action on Pharmacy Benefit Manager Reform

The National Association of Attorneys General (NAAG) sent a letter to Congressional leaders on behalf of 39 attorneys general who urge congressional leaders to engage in meaningful debate and reform of the current practices of pharmacy benefit managers (PBMs) and to take decisive action to reform the way PBMs conduct business and bring more transparency…

Read More →

FTC and Plaintiff States v. Syngenta Crop Protection AG, No. 22-cv-828 (M.D. N.C. Nov. 2022)

The FTC and 10 states sued pesticide manufacturers Syngenta Crop Protection and Corteva, Inc. two of the largest pesticide manufacturers operating in the United States. For allegedly paying distributors to block competitors from selling their cheaper generic products to farmers. The complaint alleges that these big pesticide firms run so-called “loyalty programs” in which distributors…

Read More →

45 State Attorneys General Join in their Ongoing Efforts to Protect Consumers from Robocalls

A bi-partisan coalition of 45 state attorneys general sent a letter to the Federal Communications Commission (FCC) seeking to safeguard consumers from scam phone calls made by Voice-Over-Internet-Protocol (VoIP) service providers. The attorneys general submitted comments to the FCC on its proposal “to safeguard and secure the open Internet” (NPRM) asking it to clarify that…

Read More →

Ohio et al. v. National Collegiate Athletic Association (NCAA), No. 1:23-cv-00100 (N.D. W.V. Dec. 7, 2023)

Seven plaintiff states filed suit against the NCAA, alleging that the NCAA’s transfer eligibility rule is an illegal restraint on college athletes’ ability to market their labor and control their education.  The rule requires college athletes who transfer among Division 1 schools to wait one year before competing in games, unless they obtain a waiver…

Read More →

54 Attorneys General Call on Congress to Study AI and Its Harmful Effects on Children

A bipartisan coalition of 54 state and territory attorneys general urge Congress to study how artificial intelligence (AI) can and is being used to exploit children through child sexual abuse material (CSAM). The attorneys general also asked Congress to propose legislation that would protect children from those abuses. The National Association of Attorneys General (NAAG)…

Read More →

Attorneys General Call on Congress to Pass the Combating Illicit Xylazine Act

A bipartisan coalition of 39 state and territory attorneys general called on leaders of Congress to pass the Combating Illicit Xylazine Act (H.R.1839/S.993). Xylazine is only approved by the U.S. Food and Drug Administration (FDA) as a veterinary medicine and in humans, it is known to depress breathing and heart rate, lower blood pressure, and…

Read More →

Attorneys General Urge Congress to Appropriate Funding for Legal Services Corporation

A bipartisan coalition of 37 state and territory attorneys general urge leaders of the U.S. House and Senate Appropriations Committees to allocate robust funding for the nonprofit Legal Services Corporation (LSC) in the FY2024 budget. LSC supports equal access to justice by awarding grants to nonprofit organizations that provide civil legal services to those in…

Read More →

Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)

44 plaintiff states filed suit against Teva Pharmaceuticals and 19 of the nation’s largest generic drug manufacturers alleging a broad conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs. The lawsuit was originally Connecticut, was transferred to the MDL court in Pennsylvania.  The lawsuit…

Read More →

Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)

Plaintiff states filed a third lawsuit stemming from the ongoing antitrust investigation into a widespread conspiracy by generic drug manufacturers to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States. The complaint focuses on 80 topical generic drugs  and names 26 corporate Defendants and 10…

Read More →

U.S. and Plaintiff States v. Nexstar Media Group et al., No. 19-02295 (D.D.C. 08/01/19)

Nexstar agreed to acquire Tribune Media Company for approximately $6.4 billion. USDOJ and plaintiff states sued, alleging that the merger would likely substantially lessen competition in thirteen Designated Market Areas (DMAs).  MVPDs, such as Comcast, DirecTV, and Charter, typically pay the owner of local broadcast stations in a given DMA a per-subscriber fee for the…

Read More →